These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
648 related items for PubMed ID: 21721597
21. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Heffelfinger JD, Dowell SF, Jorgensen JH, Klugman KP, Mabry LR, Musher DM, Plouffe JF, Rakowsky A, Schuchat A, Whitney CG. Arch Intern Med; 2000 May 22; 160(10):1399-408. PubMed ID: 10826451 [Abstract] [Full Text] [Related]
22. Improving outcomes of elderly patients with community-acquired pneumonia. Gutiérrez F, Masiá M. Drugs Aging; 2008 May 22; 25(7):585-610. PubMed ID: 18582147 [Abstract] [Full Text] [Related]
23. Antibiotic treatment outcomes in community-acquired pneumonia. Çilli A, Sayıner A, Çelenk B, Şakar Coşkun A, Kılınç O, Hazar A, Aktaş Samur A, Taşbakan S, Waterer GW, Havlucu Y, Kılıç Ö, Tokgöz F, Bilge U. Turk J Med Sci; 2018 Aug 16; 48(4):730-736. PubMed ID: 30119147 [Abstract] [Full Text] [Related]
24. Clinical efficacy of new antibacterial therapies in at-risk populations. Lorenz J. J Infect; 2002 Feb 16; 44 Suppl A():25-30. PubMed ID: 12150492 [Abstract] [Full Text] [Related]
29. [Pay attention to new evolution trends in the etiology of community-acquired pneumonia in adults]. He LX. Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jun 12; 47(6):576-581. PubMed ID: 38858211 [Abstract] [Full Text] [Related]
33. Comparison of beta-lactam and macrolide combination therapy versus fluoroquinolone monotherapy in hospitalized Veterans Affairs patients with community-acquired pneumonia. Lodise TP, Kwa A, Cosler L, Gupta R, Smith RP. Antimicrob Agents Chemother; 2007 Nov 12; 51(11):3977-82. PubMed ID: 17709460 [Abstract] [Full Text] [Related]
38. Risk factor-based analysis of community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia: Microbiological distribution, antibiotic resistance, and clinical outcomes. Hyun H, Song JY, Yoon JG, Seong H, Noh JY, Cheong HJ, Kim WJ. PLoS One; 2022 Apr 12; 17(6):e0270261. PubMed ID: 35767562 [Abstract] [Full Text] [Related]
39. Ceftaroline fosamil as a potential treatment option for Staphylococcus aureus community-acquired pneumonia in adults. Welte T, Kantecki M, Stone GG, Hammond J. Int J Antimicrob Agents; 2019 Oct 12; 54(4):410-422. PubMed ID: 31404620 [Abstract] [Full Text] [Related]
40. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. Jacobs MR, Felmingham D, Appelbaum PC, Grüneberg RN, Alexander Project Group. J Antimicrob Chemother; 2003 Aug 12; 52(2):229-46. PubMed ID: 12865398 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]